Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04351113 · ClinicalTrials.gov registry record · NA

Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse

A NA study of Aging and Oxidative Stress, sponsored by Joel Trinity.

Recruiting
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT04351113: Recruiting NA study of Aging and Oxidative Stress, sponsored by Joel Trinity.

NCT04351113 is a NA study of Aging and Oxidative Stress that is actively recruiting participants, run by Joel Trinity. The registered enrollment target is 72 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04351113, a NA study of Aging and Oxidative Stress, is actively recruiting participants, sponsored by Joel Trinity.

RECRUITING
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

Prolonged periods of reduced activity are associated with decreased vascular function and muscle atrophy. Physical inactivity due to acute hospitalization is also associated with impaired recovery, hospital readmission, and increased mortality. Older adults are a particularly vulnerable population as functional (vascular and skeletal muscle mitochondrial dysfunction) and structural deficits (loss in muscle mass leading to a reduction in strength) are a consequence of the aging process. The combination of inactivity and aging poses an added health threat to these individuals by accelerating the negative impact on vascular and skeletal muscle function and dysfunction. The underlying factors leading to vascular and skeletal muscle dysfunction are unknown, but have been linked to increases in oxidative stress. Additionally, there is a lack of understanding of how vascular function is impacted by inactivity in humans and how these changes are related to skeletal muscle function. It is our goal to investigate the mechanisms that contribute to disuse muscle atrophy and vascular dysfunction in order to diminish their negative impact, and preserve vascular and skeletal muscle function across all the lifespan.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT MITO-AO
  • DIETARY_SUPPLEMENT PB-125
  • OTHER Passive Leg Movement (PLM)
  • OTHER Plantar flexion

Study Locations (1)

Utah

  • VA Medical Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2019-09-01
Est. Completion 2025-12-31
Phase NA
Joel Trinity

1 total trials

What NCT04351113 shows while recruiting

NCT04351113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower).

The record links to 5 conditions, with Aging appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.

NCT04351113 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT04351113 about?

NCT04351113 is a clinical study titled "Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse". Prolonged periods of reduced activity are associated with decreased vascular function and muscle atrophy. Physical inactivity due to acute hospitalization is also associated with impaired recovery, hospital readmission, and increased mortality. Older adults are a particularly vulnerable population a...

What is the current status of trial NCT04351113?

This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2019-09-01. Estimated completion is 2025-12-31.

What conditions does trial NCT04351113 study?

This clinical trial studies the following conditions: Aging, Oxidative Stress, Skeletal Muscle, Vascular Endothelium, Antioxidants.

What interventions are being tested in trial NCT04351113?

The interventions under investigation include: Placebo (OTHER), MITO-AO (DIETARY_SUPPLEMENT), PB-125 (DIETARY_SUPPLEMENT), Passive Leg Movement (PLM) (OTHER), Plantar flexion (OTHER).

Who is sponsoring clinical trial NCT04351113?

This trial is sponsored by Joel Trinity, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04351113 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04351113's enrollment target sits among peer trials

72 118th of 262 higher than 140 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04351113, the US trial registry maintained by the National Library of Medicine. NCT04351113 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.